Form 8-K · Current report
Dover Corporation 8-K, filed Jul 23, 2026
- Filed
- CIK
- 0000029905
- Accession no.
- 0000029905-26-000026
Summary
Dover Corporation reported second-quarter 2026 revenue of $2.2 billion, up 7% year over year, and raised its full-year adjusted EPS guidance to $10.55-$10.75. CEO Richard J. Tobin said all five segments delivered positive organic growth and bookings grew double digits.
Key points
- Dover's second-quarter 2026 revenue rose 7% to $2.2 billion, including 5% organic growth.
- GAAP diluted EPS from continuing operations increased 14% to $2.31, while adjusted diluted EPS rose 12% to $2.74.
- Dover raised full-year 2026 adjusted EPS guidance to $10.55-$10.75 and expects revenue growth of 6%-8%.
- CEO Richard J. Tobin said all five segments delivered positive organic growth and bookings outpaced shipments with double-digit growth.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 23, 2026, Dover Corporation ("Dover") issued the Press Release attached hereto as Exhibit 99.1 announcing its results of operations for the quarter ended June 30, 2026. The information in this Current Report on Form 8-K, including Exhibit 99.1, is being furnished to the Securities and Exchange Commission (the “SEC”) and shall not be deemed to be incorporated by reference into any of Dover’s filings with the SEC under the Securities Act of 1933, as amended. Item 7.01 Regulation FD Disclosure. As previously announced, on July 23, 2026, Dover will hold an investor conference call and webcast at 8:30 a.m. Central time (9:30 a.m. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.